Gyala, Therapeutics

Gyala Therapeutics inicia un ensayo clínico de fase I/ IIa de una terapia con células CAR-T

Published on 03/19/2026 at 13:11 | prnewswire.co.uk

Gyala Therapeutics Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America

en | boerse | 68863447 |